Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic stents for benign prostatic hyperplasia.

L T Klein1, S A Kaplan

  • 1Department of Urology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Journal of Long-Term Effects of Medical Implants
|December 8, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Cell communication and signaling : CCS·2021
Same author

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

International journal of clinical practice·2014
Same author

Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Drugs & aging·2014
Same author

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

Current bladder dysfunction reports·2013
Same author

Systematic review of the relationship between bladder and bowel function: implications for patient management.

International journal of clinical practice·2013
Same author

A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.

International journal of clinical practice·2012
Same journal

Impact of Subgingival Lactobacillus reuteri Probiotic Therapy on Clinical Outcomes and Porphyromonas gingivalis Quantification in Peri-Implant Disease: A Prospective RT-PCR-Based Clinical Study.

Journal of long-term effects of medical implants·2026
Same journal

Prevalence of Peri-Implant Disease in Treated Chronic Periodontitis Patients on Supportive Therapy: A Cross-Sectional Evaluation After 1 Year of Implant Function.

Journal of long-term effects of medical implants·2026
Same journal

Hormonal Transition and Osseointegration: Evaluating the Nexus between Vitamin D Status and Peri-Implant Health and Disease in Women.

Journal of long-term effects of medical implants·2026
Same journal

Therapeutic Impact of Systemic Probiotics Combined with Mechanical Debridement in Peri-Implant Disease: A Clinical and Microbiological Evaluation.

Journal of long-term effects of medical implants·2026
Same journal

A Comprehensive Histomorphometric and Surface Roughness Evaluation of Sandblasted Acid-Etched (SLA) Titanium Alloy Implants: Perspectives from an Experimental Rabbit Osseointegration Analysis.

Journal of long-term effects of medical implants·2026
Same journal

Flapless Graft-Free Sinus Floor Elevation Simultaneously with the Placement of a Dental Implant "Aldary Technique": A Case Report with 5 Years Follow-Up.

Journal of long-term effects of medical implants·2026
See all related articles

Benign prostatic hyperplasia (BPH) treatments are evolving, with prostatic stents offering a new option for elderly or medically complex patients. This review details available stent types and clinical trials.

Area of Science:

  • Urology
  • Medical Devices

Background:

  • Benign prostatic hyperplasia (BPH) treatment options have advanced significantly.
  • Current treatments include surgery, medication, and minimally invasive methods like prostatic stents.

Purpose of the Study:

  • To provide an updated discussion on available prostatic stent types.
  • To review recent clinical trials evaluating prostatic stent efficacy.

Main Methods:

  • Literature review of current treatment modalities for BPH.
  • Analysis of clinical trial data for prostatic urethral stents.

Main Results:

  • Prostatectomy is highly effective for severe obstruction (85-90% success).
  • Medical therapies are popular for mild to moderate BPH.

Related Experiment Videos

  • Prostatic stents are emerging in Europe and Asia, with limited US adoption due to regulatory and indication debates.

    • Conclusions:

    • Prostatic stents show promise for BPH patients who are frail, elderly, or have comorbidities.
    • Further investigation and regulatory clarity are needed for wider US adoption of prostatic stents.